4927:TSEPola Orbis Holdings Inc. Analysis
Data as of 2026-06-19 - not real-time
NT$51.10
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Apex International trades at a forward P/E of 6.38, dramatically below the industry average of 38, and its price‑to‑book (2.76) and price‑to‑sales (1.21) ratios suggest a superficially cheap valuation. However, the fundamentals are severely strained: revenue fell 12%, gross margin is negative (-5.7%), operating margin sits at -26%, and the company carries a massive debt load (debt‑to‑equity 191%). Cash generation is negative, with operating cash flow and free cash flow both in the hundreds of millions of TWD deficit.
Technically, the stock sits below its 20‑day (53.6) and 50‑day (52.7) moving averages, the MACD is bearish, and volume is declining, indicating short‑term weakness despite a bullish trend label. Volatility is extreme (73% 30‑day), beta is near‑neutral (0.93), and the market sentiment index shows "Extreme Greed," which may be overstating the upside given the underlying financial distress.
Technically, the stock sits below its 20‑day (53.6) and 50‑day (52.7) moving averages, the MACD is bearish, and volume is declining, indicating short‑term weakness despite a bullish trend label. Volatility is extreme (73% 30‑day), beta is near‑neutral (0.93), and the market sentiment index shows "Extreme Greed," which may be overstating the upside given the underlying financial distress.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and decreasing volume
- Negative earnings and cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for turnaround if debt is restructured
- Valuation still attractive on a forward basis
- High volatility and uncertain operating recovery
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained high leverage and weak profitability
- Exposure to cyclical electronic components demand
- Limited upside without significant operational improvement
Key Metrics & Analysis
Financial Health
Revenue Growth-12.00%
Profit Margin-22.65%
P/E Ratio6.4
ROE-44.04%
ROA-6.87%
Debt/Equity191.15
P/B Ratio2.8
Op. Cash FlowNT$-1228942976
Free Cash FlowNT$-417409376
Industry P/E38.1
Technical Analysis
TrendBullish
RSI48.1
SupportNT$46.65
ResistanceNT$65.90
MA 20NT$53.62
MA 50NT$52.68
MA 200NT$36.25
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.93
Volatility73.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.